Mesenchymal Stem Cell-based Therapy and Female Infertility: Limitations and Advances

Area of Science:

• Reproductive Medicine
• Regenerative Medicine
• Stem Cell Biology

Background:

• Female infertility stems from conditions like premature ovarian failure (POF), polycystic ovary syndrome (PCOS), endometriosis, and Asherman syndrome.
• These conditions significantly impact couples' quality of life, causing emotional and physical distress.
• Traditional infertility treatments often lack efficacy and invasiveness, prompting research into novel therapeutic strategies.

Purpose of the Study:

• To review female reproductive disorders and their conventional treatments.
• To evaluate recent advancements in applying mesenchymal stem cells (MSCs) for infertility.
• To highlight the potential of MSCs in improving women's reproductive health.

Main Methods:

• Literature review of female reproductive disorders and current treatments.
• Analysis of recent studies on mesenchymal stem cell (MSC) applications in gynecological disorders.
• Evaluation of MSC properties, including multipotency, proliferation, and regenerative capabilities.

Main Results:

• Mesenchymal stem cells (MSCs) show significant potential in regenerative medicine due to their unique properties.
• MSCs offer a promising alternative to traditional infertility treatments with fewer ethical concerns than embryonic stem cells.
• Their therapeutic effects are mediated through cell homing, secretion of bioactive factors, and immune modulation.

Conclusions:

• Mesenchymal stem cells (MSCs) represent a novel and effective therapeutic avenue for various causes of female infertility.
• Further understanding of MSCs' functional mechanisms is crucial for their clinical integration in reproductive medicine.
• MSC-based therapies hold promise for enhancing reproductive health and addressing gynecological disorders globally.